Ignyte BIO specializes in the development and provision of well-characterized immune cell products, particularly focusing on antigen-specific T cells (ASpecT). These T cells are crucial for T cell biology research and potency assays, as they can be isolated from disease sites or generated in vitro. The company emphasizes the reliability of their ASpecT products, which are created through multiple in vitro stimulations with peptide antigens. Unlike immortalized or genetically modified cells, these T cells closely resemble physiological conditions, with their specificity validated through peptide/MHC tetramer binding and functional assays such as interferon-gamma secretion and cytotoxicity.

In addition to ASpecT, Ignyte BIO offers a comprehensive catalog of human Peripheral Blood Mononuclear Cells (PBMC), which are essential for various biomedical research applications, including immunology and toxicology. Their offerings include normal, irradiated, and diseased PBMC samples, each meticulously prepared to ensure high viability and purity. This diverse range of immune cell products supports researchers in studying immune responses and developing immunotherapies, while the company also provides custom product development and consulting services to optimize research efforts across pharma, biotech, and academic sectors.

United States

While biopharma research is complex, biosourcing shouldn't be. We provide human immune cells, along with custom development and consulting services. Our scientists have decades of experience solving complex biomaterial and product development challenges for leading biopharma companies, CROs, and academic research institutions.

Ignyte BIO

Company Details